Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitinib & Erlotinib, 2nd Gen Afatinib & Dacomitinib, 3rd Gen Osimertinib, Combos With VEGF or Chemo, Exon 20 Insertions | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

GRACE

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitinib & Erlotinib, 2nd Gen Afatinib & Dacomitinib, 3rd Gen Osimertinib, Combos With VEGF or Chemo, Exon 20 Insertions

By GRACE FEATURING Jared Weiss

By GRACE FEATURING Jared Weiss

207 views

March 1, 2021

Comments 0

Login to view comments. Click here to Login